Catalyzing pathways for translational research beyond COVID-19
Emergency action in response to the COVID-19 pandemic led to the removal of financial and regulatory barriers to developing medical technologies. But, as Andrea Armani and Eric Diebold explain, a broader cultural shift in academia can expedite their translation from laboratory benches to real-world...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/265ef686a91c4d69a4194be7d114f496 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Emergency action in response to the COVID-19 pandemic led to the removal of financial and regulatory barriers to developing medical technologies. But, as Andrea Armani and Eric Diebold explain, a broader cultural shift in academia can expedite their translation from laboratory benches to real-world use. |
|---|